https://european-biotechnology.com/wp-content/uploads/2024/04/Eppendorf_AG_press_image_epT.I.P.S._Box_2.0.jpg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-09-12 10:28:002024-04-02 15:51:01Facelift for reusable pipette tip boxes
At the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board.
EnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline.
Owlstone Medical has raised US$59m in a Series D financing round. The proceeds will be used to continue development of the companys breath biopsy tests.
https://european-biotechnology.com/wp-content/uploads/2024/04/coronavirus-4952102_1920.jpg12801920Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2021-09-07 09:17:002021-09-07 09:17:00Owlstone: US$59m for breath biopsy development
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2021-09-06 15:22:122021-09-06 15:22:12Byondis with new Senior Director
The EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine doses. They agreed to a new delivery schedule.
Swiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases.
With new backing from large pharma, rising investors interest, and new incubators on stage, the AMR community is now urging policy makers worldwide to bring pull incentives into reality.
https://european-biotechnology.com/wp-content/uploads/2024/04/2021_09_02_amrconf.jpg405720Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-08-30 05:46:002021-08-30 05:46:00Call for pull incentives to get started
Facelift for reusable pipette tip boxes
ProductsThe new box is now called Box 2.0. The new design is a consistent, modern further development of the original product outfit.
Change in Solys BioDyne Management
AppointmentsAt the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board.
US$21m for microbiome therapies
Latest NewsEnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline.
Swiss Biotech Day shows great biopharma ambitions
Latest NewsThe Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel.
Owlstone: US$59m for breath biopsy development
Latest NewsOwlstone Medical has raised US$59m in a Series D financing round. The proceeds will be used to continue development of the companys breath biopsy tests.
Byondis with new Senior Director
AppointmentsTimo van den Berg is the new senior director Immuno-Oncology Research and Development at Byondis B.V. He joined the company at beginning
EU ends litigation with AstraZeneca
Latest NewsThe EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine doses. They agreed to a new delivery schedule.
EuropaBio lobbies for better Orphan Drug rules
Latest NewsEuropaBio has responded to the European Commissions public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
VectivBio expands rare disease pipeline
Latest NewsSwiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases.
Call for pull incentives to get started
Latest NewsWith new backing from large pharma, rising investors interest, and new incubators on stage, the AMR community is now urging policy makers worldwide to bring pull incentives into reality.